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Abstract
Background: Antibiotic-resistant Klebsiella pneumoniae are a major cause of hospital- and community-acquired
infections, including sepsis, liver abscess, and pneumonia, driven mainly by the emergence of successful high-risk
clonal lineages. The K. pneumoniae sequence type (ST) 307 lineage has appeared in several different parts of the
world after first being described in Europe in 2008. From June to October 2019, we recorded an outbreak of an
extensively drug-resistant ST307 lineage in four medical facilities in north-eastern Germany.
Methods: Here, we investigated these isolates and those from subsequent cases in the same facilities. We
performed whole-genome sequencing to study phylogenetics, microevolution, and plasmid transmission, as
well as phenotypic experiments including growth curves, hypermucoviscosity, siderophore secretion, biofilm
formation, desiccation resilience, serum survival, and heavy metal resistance for an in-depth characterization of
this outbreak clone.
Results: Phylogenetics suggest a homogenous phylogram with several sub-clades containing either isolates
from only one patient or isolates originating from different patients, suggesting inter-patient transmission. We
identified three large resistance plasmids, carrying either NDM-1, CTX-M-15, or OXA-48, which K. pneumoniae
ST307 likely donated to other K. pneumoniae isolates of different STs and even other bacterial species (e.g.,
Enterobacter cloacae) within the clinical settings. Several chromosomally and plasmid-encoded, hypervirulence-
associated virulence factors (e.g., yersiniabactin, metabolite transporter, aerobactin, and heavy metal resistance
genes) were identified in addition. While growth, biofilm formation, desiccation resilience, serum survival, and
heavy metal resistance were comparable to several control strains, results from siderophore secretion and
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hypermucoviscosity experiments revealed superiority of the ST307 clone, similar to an archetypical, hypervirulent K.
pneumoniae strain (hvKP1).
Conclusions: The combination of extensive drug resistance and virulence, partly conferred through a “mosaic” plasmid
carrying both antibiotic resistance and hypervirulence-associated features, demonstrates serious public health
implications.
Keywords: XDR Klebsiella pneumoniae, Outbreak, Hypervirulence, Plasmid transmission, “Mosaic” plasmid
Background
Klebsiella pneumoniae cause severe infections including
sepsis, liver abscess, and pneumonia [1, 2]. The emer-
gence of multidrug-resistant (MDR) and extensively
drug-resistant (XDR), “classic” K. pneumoniae (cKp) has
been mainly driven by the dissemination of high-risk
clonal lineages and now constitutes a major global pub-
lic health problem [3]. The majority of cKp strains cause
infection in immunocompromised patients in healthcare
settings and have demonstrated the ability to acquire
antibiotic resistance elements. In addition to this cKp, a
second pathotype termed hypervirulent K. pneumoniae
(hvKp) is currently circulating, particularly in Asia but
with increasing reports from other countries [2, 4]. The
hvKp’s defining features are clinical characteristics in-
cluding multiple site infection and metastatic spread in
the healthy community [5] and, originally, a positive la-
boratory string test indicating a hypermucoid phenotype
[6]. The definition of hypervirulence is controversial,
however [7]. A recent study identified potential
biomarkers including peg-344, iroB, iucA, plasmid-borne
rmpA and rmpA2 genes, and high siderophore
production in hvKp to accurately differentiate the two
pathotypes [8].
While K. pneumoniae sequence type (ST) 258 has
been recognized as antibiotic-resistant, high-risk clonal
lineage [9], ST307 came into spotlight only more
recently [3, 10, 11]. The first K. pneumoniae ST307 iso-
lates were obtained in the Netherlands in 2008 and
Pakistan in 2009, followed by a period of sporadic isola-
tions across Europe, Asia, Africa, and the Americas [11],
and originated mostly, but not uniquely, from clinical
samples [3, 10]. A phylogenetic study suggests the emer-
gence of two deep-branching ST307 lineages, one of glo-
bal relevance with genomes from locations worldwide
and evidence of intercontinental transfer [10]. The other
lineage included K. pneumoniae ST307 isolates from
Texas, USA [12]. Within the global lineage, some iso-
lates also originated from the infections in Texas [12],
which suggests that the USA may have been the origin
of this sequence type, especially as most of its genetic di-
versity was present in that location [10]. ST307 often
carries transferable resistance-conferring genes against
carbapenems and newer-generation cephalosporins like
blaKPC-3, blaNDM-1, blaOXA-48, and blaCTX-M-15 [3, 10].
Resistance to the novel combination ceftazidime/avibac-
tam [13] and to colistin was also reported [14, 15].
Besides that, the ST307 K. pneumoniae lineage com-
prises a variety of additional resistance and virulence de-
terminants, integrative conjugative elements, and phages
[3, 10]. There are several outbreak reports on MDR K.
pneumoniae ST307 in clinical settings [16–18].
In this study, we analyzed carbapenemase-producing
ST307 isolates, which have been recovered from screen-
ing and clinical samples within the course of an outbreak
[19] that took place in four medical facilities in Western
Pomerania, Germany, from June 2019 to October 2019.
Additional cases were detected after the actual outbreak
in the beginning of 2020. These isolates were character-
ized as carrying NDM-1 and OXA-48 carbapenemase-
encoding genes, mostly simultaneously, and tested
colistin-resistant. We performed whole-genome sequen-
cing and phenotypic experiments to enable functional
genomics for the in-depth understanding of this XDR
outbreak clonal lineage.
Methods
Sequenced isolates and metadata
Between June 2019 and February 2020, we investigated
56 enterobacterial isolates from 25 different patients in-
volved in the outbreak. In addition to K. pneumoniae,
we included all other Enterobacteriaceae that matched
the carbapenem-resistant phenotype. Most isolates were
obtained from rectal (n = 23) or throat/tracheal secretion
(n = 17) swabs collected as part of an extensive
surveillance program in the affected clinical institutions
(Additional file 2: Table S1). Initial antibiotic susceptibil-
ity testing (AST) was performed using the VITEK 2
(bioMérieux, Nürtingen, Germany) system and 96-well
plate broth microdilution (Merlin, Bornheim-Hersel,
Germany). Bacterial species were initially identified by
MALDI-TOF MS (VITEK MS, bioMérieux, Nürtingen,
Germany). For rapid detection of carbapenemase genes,
a loop-mediated isothermal amplification (LAMP) assay
(eazyplex SuperBug CRE, AmplexDiagnostics, Gars,
Germany) was subsequently included in the University
Medicine laboratory diagnostic program [19]. Almost
59% (33/56) of the isolates were assigned to “infection”
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samples. Clinical data and outcomes of 17 initial cases
have been published elsewhere [19]. Most of these had
severe underlying diseases. Patients were treated with
ceftazidime-avibactam/aztreonam with synergistic
activity. By October, six patients had died. Causal associ-
ations with the outbreak clone as well as clinical
outcomes of other cases are still under investigation,
however. Epidemiologic links among the different insti-
tutions were identified (Additional file 2: Table S1).
Samples were incubated overnight on CHROMID
CARBA and CHROMID ESBL agar plates (bioMérieux,
Nürtingen, Germany), and single colonies were picked
for identification with VITEK MS (bioMérieux, Nürtin-
gen, Germany). Antimicrobial susceptibility testing was
carried out using VITEK 2 (bioMérieux, Nürtingen,
Germany), and in addition, 96-well plate broth microdi-
lution was performed for determination of colistin MICs
(Merlin, Bornheim-Hersel, Germany).
Whole-genome sequencing
We generated 52 K. pneumoniae, 2 E. coli, 1 C. freundii,
and 1 E. cloacae whole-genome sequences on different se-
quencing machines (MiGS: Illumina NextSeq 550; LGC:
Illumina NextSeq 500; Eurofins: Illumina NovaSeq 6000).
Two K. pneumoniae isolates (PBIO1953 [va20750],
PBIO1951 [va19352]) were long-read sequenced using
ONT’s Nanopore system. Additional file 2: Table S1
shows the respective metadata including origin institution,
sampling location, and patient pseudonym. From 13 pa-
tients, more than one isolate was sequenced (11 patients
with more than one K. pneumoniae isolate; 9 patients with
more than one K. pneumoniae ST307 isolate). Some
ST307 isolates were obtained from multiple sites from the
same patient (e.g., PT17). DNA was extracted using the
MasterPure™ DNA Purification Kit for Blood, Version II
(Lucigen, Middleton, USA). After quantification and initial
quality control, DNA was shipped to MiGS (Microbial
Genome Sequencing Center, Pittsburgh, USA), LGC
(LGC Genomics GmbH, Berlin, Germany), and Eurofins
(Eurofins Genomics Europe Sequencing GmbH, Con-
stance, Germany) and following library preparation with
[20] (MiGS), the SeqWell™ Kit (LGC), and an adapted
NEBNext Ultra™ II FS DNA Library Prep Kit (Eurofins)
sequenced using 2 × 150 bp paired-end reads.
Assembly and annotation
Raw sequencing reads were adapter-trimmed, contaminant-
filtered, and quality-trimmed using BBDuk from BBTools v.
38.41 (http://sourceforge.net/projects/bbmap/). Both trimmed
reads and raw reads were quality-controlled using FastQC v.
0.11.8 (http://www.bioinformatics.babraham.ac.uk/projects/
fastqc/). De novo genome assemblies were conducted by
employing the assembly pipeline shovill v. 1.0.4 (https://
github.com/tseemann/shovill) in combination with SPAdes v.
3.13.1/3.14.0 [21]. As part of the pipeline, trimmed reads were
subsampled to assemble at a maximum coverage of 100×. Be-
sides the polishing step as part of the shovill pipeline, assem-
blies underwent an additional polishing step. For this, all
trimmed reads were mapped back to the contigs using bwa v.
0.7.17 [22]. The obtained SAM/BAM files were sorted with
Samtools v. 1.9 [23] and optical duplicates marked with
GATK v. 4.1.2.0 [24]. Finally, variants were called with Pilon
v. 1.23 [25]. The genomes of strains for which additional
long-read sequencing data were obtained were hybrid-
assembled with Unicycler v. 0.4.8 [26]. To verify the “hybrid”
nature of plasmid 1, we mapped the long-reads of PBIO1953
back to the assembly using minimap2 v. 2.17 [27] and visual-
ized the alignment with Tablet v. 1.19.09.03 [28] (Add-
itional file 1: Fig. S1). The assembly graphs of putative
plasmid recipient isolates and the closed reference isolate
PBIO1953 were inspected with Bandage v. 0.8.1 [29] and its
integrated BLAST hit (Megablast, ≥ 99% identity, E value 1e
−10) visualization (Additional file 1: Fig. S2). Genome quality
and completeness were assessed with CheckM v. 1.0.13 [30].
We used Prokka v. 1.14.1 [31] to annotate draft and finished
genomes automatically.
Genomic analysis
The in silico multi-locus sequence typing (MLST) and
antibiotic resistance/virulence gene detection were
carried out using mlst v. 2.19.0 (https://github.com/tsee-
mann/mlst) and ABRicate v. 0.9.9 (https://github.com/
tseemann/abricate), respectively. Both tools rely on 3rd-
party public databases (e.g., PubMLST [32], VFDB [33],
ResFinder [34], PlasmidFinder [35], BacMet [36]). To
visualize draft genome content, BRIG v. 0.95-dev.0004
[37] and NCBI BLAST v. 2.9.0+ [38] with a threshold of
at least 99% identity were employed by aligning isolate
contigs against the respective reference. Pangenome
analysis was performed with Roary v. 3.12.0 [39]. For in-
depth typing of yersiniabactin, aerobactin, K locus, and
O locus, we used Kleborate v. 1.0.0 with Kaptive [40–
43]. A synteny plot comparing plasmid 1 (pPBIO1953_
NDM-1) and plasmid 2 (pPBIO1953_CTX-M-15) of
PBIO1953 with K. pneumoniae virulence plasmids
pK2044 [44] and pKCTC2242 [45] was created with gen-
oPlotR v. 0.8.9 [46].
Phylogeny
We created a core SNP phylogeny for ST307 including
(a) only the 44 ST307 isolates from this study (outbreak
phylogeny) (Fig. 1) and (b) the 44 ST307 isolates as well
as 97 publicly available ST307 genomes (79 as raw reads,
18 as assembly) (global phylogeny) (Additional file 2:
Table S2). SNPs were called from the finished genome
of PBIO1953 using snippy v. 4.4.1 (https://github.com/
tseemann/snippy). Alignments were filtered for recombi-
nations using Gubbins v. 2.4.1 [47] and core SNPs
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extracted using snp-sites v. 2.5.1 (83 sites for the out-
break phylogeny; 1476 sites for the global phylogeny)
[48]. A maximum likelihood tree was inferred with
RAxML-NG v. 0.9.0 [49] using GTR+G. The best-
scoring maximum likelihood tree was midpoint-rooted
in iTOL v. 5.5 [50] and visualized with metadata. An
additional phylogenetic tree of all isolates was inferred
based on whole genomes with the help of JolyTree v.
1.1b.191021ac [51] and visualized with iTOL v. 5.5 [50].
Pathway analysis of variants
Single-nucleotide polymorphisms detected among the K.
pneumoniae ST307 genomes were filtered for missense,
frameshift, and stop-gained variants and respective genes
subjected to metabolic pathway analysis using the EcoCyc
(https://ecocyc.org/) [52] database (reference: Klebsiella
pneumoniae “KpvST383_NDM_OXA-48” [NCBI Biosam-
ple number: SAMN10409888] [53]).
Bacterial isolates and PCV construction
For phenotypic experiments, we used a selection of five K.
pneumoniae ST307 outbreak isolates (PBIO1953,
PBIO2000, PBIO1935, PBIO1994, PBIO1993) and three
non-ST307 K. pneumoniae present during the outbreak
(PBIO1951 and PBIO1961 [ST395], PBIO1979 [ST405])
(Additional file 2: Table S1). They were compared against
three K. pneumoniae with different sequence types: a
common ESBL-producing reference (ATCC700603
[ST498]), one of the ubiquitously occurring K. pneumo-
niae lineage ST15 (PBIO2008), and one archetypal, hyper-
virulent K. pneumoniae strain (hvKP1, ST86) [6, 54]. In
addition, we included a non-carbapenemase-producing K.
pneumoniae ST307 isolate from a previous study
Fig. 1 Core SNP phylogeny of K. pneumoniae ST307 isolates. The phylogenetic tree was inferred with a maximum likelihood-based approach and
is based on a core SNP alignment (83 sites). The (midpoint-rooted) tree is shown with bootstrap proportions for values ≥ 50% (1000 replicates;
filled circles on branches) and additional metadata. The patient associated with isolate PBIO1964 (PT06) was initially present on a submission ward
for bacterial isolation but later on transferred to a different ward. Abbreviations: UMG, University Medicine Greifswald; WLG, clinic in Wolgast; BDH,
clinic in Greifswald; KB, clinic in Karlsburg
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(IMT38405 [PBIO2009]) [11] and a “plasmid-cured” vari-
ant (PCV1935) stemming from PBIO1935. Based on a
previously published protocol [55], this mutant was con-
structed by culturing PBIO1935 for 7 days at 42 °C and
using ceftazidime/avibactam (16 μg/mL) as selection
marker to identify NDM-1-plasmid-cured variants. Plas-
mid profile analysis (Additional file 1: Fig. S3A) performed
as previously described [55], and bioinformatics analysis
confirmed partial loss of plasmid 1 (Additional file 1: Fig.
S3A; dashed box) and complete loss of plasmid 3 (Add-
itional file 1: Fig. S3A; dotted box) in PCV1935.
Growth curves
Growth curves in LB medium were performed using
standardized protocols. Experiments were performed
using three technical replicates and three biological rep-
licates [56]. An E. coli K-12 strain (W3110) was used as
control. Growth rates were calculated as follows: μ =
(ln(CFU/mL t1) − ln(CFU/mL t0))/t1 − t0.
Hypermucoviscosity
Hypermucoviscosity experiments were performed using
the string test. Strings of 5 mm or longer that formed
after stretching on the tip of a sterile inoculation loop
were defined positive [6]. Experiments were performed
with three technical replicates and three biological
replicates.
Siderophore secretion
We analyzed the study’s set of isolates for their ability to
secrete siderophores using an adapted method described
by Schwyn and Neilands [57]. Fifty microliters of over-
night cultures of the isolates was grown in 5 mL fresh
LB medium to an OD600 of 0.6. Five microliters of this
culture was put on agar plates containing chrome azurol
S-iron(III)-hexadecyltrimethylammonium bromide and
incubated overnight at 37 °C. Iron uptake was deter-
mined visually by color shift from blue to yellow the fol-
lowing day. One ST131 E. coli strain (IMT21183) and
one K-12 E. coli strain (W3110) were included as con-
trols [58]. Experiments were performed with three tech-
nical replicates and three biological replicates.
Biofilm formation
We used the same set of isolates as described above and
performed a biofilm formation experiment as described
in previous reports [59]. Ten microliters of overnight
cultures of all isolates was transferred to 1 mL LB
medium and cultured at 37 °C until OD600 values of 0.6–
0.8 were reached. One hundred microliters of culture
per well was transferred to a 96-well microtiter plate.
After 3 days of static culture at 37 °C, planktonic cells
were removed from the liquid medium. The wells were
washed three times with 150 μL of double-distilled
water, and the majority of the biofilms was stained with
150 μL of 0.1% crystal violet (CV) for 30 min. Then, the
unbound dye was removed, and the plates were again
washed. Finally, the CV binding to the biofilm was dis-
solved in 150 μL of 95% ethanol for 30 min, and biofilm
formation was quantified by measuring the absorbance
at OD590 with a microplate reader (Fluostar Omega,
BMG Labtech, Ortenberg, Germany). Experiments were
performed with three technical replicates on individual
96-well microtiter plates and three biological replicates.
One biofilm-negative (PBIO729) and one positive con-
trol (W3110) [56] were included.
Serum resistance
We performed serum resistance experiments in human
serum (Pan-Biotech GmbH, Germany) as described pre-
viously [60]. We inoculated 5 μL of overnight culture in
495 μL fresh LB medium and incubated at 37 °C for 1.5
h. Inoculum was centrifuged for 3 min and resuspended
in 1 mL of sterile 1× PBS. Thirty microliters was added
in triplicates to 96-well microtiter plates containing
270 μL of 50% human serum. Thirty microliters of the
sample was collected from each well, serially diluted,
plated on LB plates, grown at 37 °C overnight, and
counted the next day (0-h count). The 96-well microtiter
plates were incubated for 4 h at 37 °C. Following incuba-
tion, 30 μL of the culture was plated, incubated, and
again counted (4-h count). Growth in serum was ob-
tained by determining differences in the CFU after 4 h of
incubation compared to the 0-h count. Experiments
were performed with three technical replicates on indi-
vidual 96-well plates and three biological replicates. An
E. coli serum-resistant control (PBIO1289, ST1159 [61])
was included.
Desiccation tolerance
Desiccation tolerance experiments for the study’s set of
isolates were performed as described previously with
some modifications [59]. A single colony was cultured in
10mL liquid LB broth until bacterial cells reached an
OD600 value of 0.6–0.8. One hundred microliters was
serially diluted, plated on LB plates, grown at 37 °C
overnight, and counted the next day (C0d, 0-day count).
Another 100 μL of the same culture was transferred into
a 96-well microtiter plate. Subsequently, the plate was
transferred into a sterile dryer with dehydrated silica gel.
The dryer was placed in a sterile incubator (Mytron,
Heilbad Heiligenstadt, Germany), which was kept at a
constant temperature of 37 °C. After 6 days of drying,
the 96-well microtiter plate was removed, 100 μL/well of
fresh medium was added, and the plate was cultured
with 200 rpm shaking at 37 °C for 3 h. One hundred mi-
croliters was collected from each well, serially diluted,
plated on LB plates, grown at 37 °C overnight, and
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counted the next day (C6d, 6-day count). Experiments
were performed with three technical replicates on indi-
vidual 96-well microtiter plates and three biological rep-
licates. An E. coli K-12 strain (W3110) was included as
control.
Heavy metal tolerance
Overnight cultures of the study’s set of isolates were ad-
justed to McFarland standard 0.5, and 50 μL of a 1:200
dilution of adjusted suspensions in Mueller-Hinton
broth (Roth, Karlsruhe, Germany) was used as inoculum
for incubations for 16 to 20 h at 37°C in heavy metal-
containing microtiter plates (Merlin Biocide plates,
Bornheim-Hersel, Germany). The plates contained a
wide range of concentrations of three heavy metals: zinc
chloride [4–8192 μg/mL], copper sulfate [32–8192 μg/
mL], and silver nitrate [0.5–64 μg/mL]. We used a
sealing tape to prevent dehydration of the plates. After
incubation, the minimum inhibitory concentration was
determined visually and reported as the tolerance break-
point. Experiments were performed with three technical
and three biological replicates. E. coli ATCC25922 was
used as control isolate.
Statistics
Statistics were performed using GraphPad Prism 8.0
(https://www.graphpad.com/). After investigating Gauss-
ian distributions, the non-parametric Kruskal-Wallis test
[62] was applied for multiple comparisons of bacterial
groups using median values. Bonferroni adjustment was
applied, which resulted in corrected p values of p < 0.016
to assess significant changes [63]. Pairwise comparison
of growth rates (μ) between all K. pneumoniae ST307
isolates and PBIO1961 was performed using the Mann-
Whitney U test (p < 0.05).
Results
Genomic analysis and phylogeny
The XDR K. pneumoniae outbreak clone was first de-
tected at the University Medicine Greifswald on June 25,
2019 (Additional file 2: Table S1), following bacterial
screening of a tracheal secretion sample [19]. Of 52 K.
pneumoniae, 44 belonged to sequence type (ST) 307,
three to ST395, three to ST11, and one each to ST405
and ST147. The two E. coli were ST405 and ST362,
whereas C. freundii was a ST153 and E. cloacae a ST45
isolate (Additional file 2: Table S1). We focused mainly
on the phylogenetics and phenotypes of the ST307 out-
break but included accessory and non-ST307 genomes
to investigate transmission of resistance plasmids within
the bacterial species and to others.
When comparing all 44 ST307 against the closed reference
genome of PBIO1953, our analysis revealed 22 single-
nucleotide polymorphisms (SNPs) at most (minimum, 6
[PBIO1958, PBIO1960, PBIO1932]; maximum, 22
[PBIO2004]; median, 11). As expected, the phylogram shows
a homogenous picture (Fig. 1; Additional file 1: Figure S4)
with several sub-clades. There are sub-clades that include
only isolates originating from the same patient (clades B [8–
11 SNPs compared to PBIO1953] and C [6–8 SNPs com-
pared to PBIO1953]) and sub-clades that comprise isolates
from different patients (clades A [14–17 SNPs compared to
PBIO1953] and D [11–15 SNPs compared to PBIO1953])
suggesting recent transmission between patients. Epidemio-
logic data support these results, for example for sub-clade D:
PT17 with isolates PBIO1965, PBIO1969, PBIO1974,
PBIO1991, PBIO1995, and PT21, from whom we obtained
isolates PBIO1936 and PBIO1970, stayed on the same ward
during the same time (September 2019). On the contrary,
PT06 with isolate number PBIO1964 was present on a differ-
ent ward during September 2019. Note, however, that PT06
was transferred later on. Interestingly, this patient underwent
endoscopy examination with the same endoscope used for
PT17 and PT21. It thus seems possible that K. pneumoniae
ST307 was transmitted among patients either by cross-
contamination through healthcare workers and surfaces or
by an endoscope as has been described previously [64].
When we placed the outbreak phylogeny in a global
context (Additional file 1: Fig. S4), we noticed that a
cluster of KPC-producing ST307 genomes originally ob-
tained from the United Kingdom (UK) (Additional file 2:
Table S2) was the phylogenetically closest to our ST307
outbreak isolates.
We then explored the distribution and character of
SNPs among the ST307 genomes (with PBIO1953 as
reference) further (Additional file 1: Fig. S5). All poly-
morphisms that were not in coding sequences (CDS)
or not assigned as missense, frameshift, or stop-
gained variants were excluded from our subsequent
analysis. We further excluded all insertion and/or de-
letion mutations (Indels). Variants accumulated al-
most uniquely in chromosomally encoded genes (59/
66). When analyzing the data of 44 annotated genes
after exclusion of hypothetical proteins in EcoCyc, we
noticed that pathways related to membrane transport
(14/44), regulation and signal transduction (9/44),
amino acid and sugar metabolism (12/44), DNA-
replication/conjugation (5/44), and lipopolysaccharide
biosynthesis (4/44) were often affected by mutations.
Thirty-seven genomes harbored a missense SNP in
the conjugation gene traI (plasmid 3) and, simultan-
eously, the topoisomerase gene gyrA, which are both
involved in plasmid conjugation and transfer [65, 66].
Interestingly, all potential K. pneumoniae ST307 plas-
mid donors belonged to this set of genomes.
We often found variants in genes encoding for mem-
brane efflux. While in sub-clade C, sotB was affected, in
other clusters, we observed missense mutations in phoE,
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gltC, and ompC. This might be an example for pheno-
copy in isolates of different sub-clades. The nitrate/ni-
trite sensor gene narX, differentiating sub-clades B
(PT19) and D (various patients), and sensor protein
pmrB, differentiating sub-clade C (PT23) from other
sub-clades (various patients), were repeatedly and inde-
pendently mutated among different patients. In addition,
two other genes, narI and narJ, displayed SNPs; both are
involved in the regulation of anaerobic respiratory gene
expression in response to nitrate and nitrite.
Several genomes obtained from the same patient demon-
strated identical variants not present in other genomes, which
could be explained by either a disruption of the infection
chain between patients or the non-advantageous character of
the mutation for dissemination. One example is the variant in
btsT, a gene involved in pyruvate uptake and present in two
isolates from the same patient over a period of 7 days.
Interestingly, the number of missense/nonsense SNPs
did not significantly increase over time during the
course of the outbreak compared to the earliest iso-
late PBIO1953 (for example PBIO1955, 8 SNPs;
PBIO1956, 11 SNPs; PBIO1957, 11 SNPs; PBIO2011,
11 SNPs; PBIO2012, 13 SNPs; and PBIO2018, 12
SNPs; Additional file 1: Fig. S5, top).
All ST307, with the exception of PBIO2003, carried
blaNDM-1, blaOXA-48, and blaCTX-M-15 resistance genes simul-
taneously, which was consistent with their phenotypes. Due
to the fact that mcr-genes were not present, phenotypic re-
sistance against colistin could not be explained by the expres-
sion of such. We identified several missense mutations in the
two-component systems PhoP/PhoQ (phoQ: 89T>A
[Leu30Gln]) and PmrA/PmrB (pmrA: 121G>A [Ala41Thr];
pmrB: 637C>A [Leu213Met], 766G>C [Gly256Arg]), typic-
ally involved in colistin resistance conferred by chromosomal
point mutations [67]. Additional mutations were present in
eptA (pmrC) (80T>G [Phe27Cys]), pmrD (179C>T
[Thr60Met]), arnT (1115A>G [Lys372Arg], 1211C>G
[Ser404Cys]), and ugd (1061A>C [Asp354Ala]) (Add-
itional file 1: Fig. S6). Three mutations (pmrB: 766G>C; eptA:
80T>G; arnT: 1115A>G) were present in colistin-susceptible
isolate PBIO1979 (ST405). Among the phenotypically
colistin-resistant isolates, four carried additional mutations in
pmrA (PBIO2001: 518T>A [Ile173Asn], 533T>C
[Ile178Thr]), pmrB (PBIO1953: 364G>C [Glu122Gln]), or
phoP (PBIO1990, PBIO1992: 563A>C [His188Pro]). Interest-
ingly, one missense mutation in pmrB (604C>A [Gln202Lys])
was exclusively present in isolates from patient PT23.
While the amino acid substitutions in PmrA/PmrB
(Ala41Thr/Leu213Met; Gly256Arg), together with an in-
sertional inactivation of mgrB, were previously reported in
a colistin-resistant K. pneumoniae ST307 isolate in 2015
[14], both this study’s colistin-susceptible and colistin-
resistant isolates showed an uninterrupted mgrB, whose
gene product is a small negative regulator of PhoQ. The
colistin-resistance phenotype is possibly explained by the
combination of several mutations in chromosomally
encoded genes.
Our analysis revealed that all ST307 genomes were
positive for the chromosomally encoded “yersiniabactin
(ybt) lineage 10” genetic makeup, associated with the K.
pneumoniae integrative conjugative element 4 (ICEKp4).
The corresponding yersiniabactin sequence type (YbST)
was 20-2LV, which is most similar to YbST20 but varies
in two loci (irp2: allele 61 instead of allele 208; fyuA: al-
lele 39 instead of allele 2). All ST307 shared “aerobactin
lineage iuc 1” signatures with aerobactin sequence type
(AbST) 63-1LV and 63 (PBIO2003); thus, all ST307 iso-
lates but one had a single-locus variant of AbST63 (SNP
in iutA). Capsule (K) and O antigen loci of K. pneumo-
niae ST307 isolates were predicted as KL102 and O2
variant 2 (O2v2) with identities of ≥ 99.25% and ≥
98.45%, respectively (Additional file 2: Table S1).
Interestingly, the NDM-1, CTX-M-15, and OXA-48
resistances were located on three different, large plas-
mids, based on their respective size subsequently termed
plasmids 1 (pPBIO1953_NDM-1), 2 (pPBIO1953_CTX-
M-15), and 4 (pPBIO1953_OXA-48) (Additional file 1:
Fig. S3 and S7). Plasmid 1 (size = 360,596 bp; incompati-
bility [Inc] types: IncFIB, IncHI1B) did not only encode
the New-Delhi metallo-beta-lactamase (NDM)-1 but also
several other resistance genes (dfrA5, sul1, sul2, qnrS1,
aph (3′)-Ia, aph (3′)-VI, armA, mph(A), mph(E), and
msr(E)) as well as virulence (peg-344/pagO, peg-1860/
pagO [metabolite transporter], iucABCD, iutA [aerobac-
tin], and rmpA/rmpA2 [regulator of mucoid phenotype])
and disinfectant/mineral resistance factors (qacEdelta1
[disinfectant resistance], ter [tellurite resistance]) (Add-
itional file 1: Fig. S7B). Plasmid 2 (size = 130,131 bp;
IncFIB) carried the following antibiotic resistances:
blaCTX-M-15, blaTEM-1B, sul2, aac (3)-IIa, aph (3″)-Ib,
and aph (6)-Id, and, interestingly, several genes respon-
sible for heavy metal resistance: ars (arsenic/antimony
resistance), sil (silver resistance), and pco (copper resist-
ance). We compared plasmids 1 and 2 to two well-
characterized, typical virulence plasmids of hypervirulent
K. pneumoniae NTUH-K2044 [44] and KCTC 2242 [45].
We found a high degree of similarity in the aforemen-
tioned virulence and mineral resistance features (Fig. 2).
This is of particular public health interest as the emer-
gence of “mosaic” plasmids carrying AMR and virulence
factors can confer both enhanced virulence and multi-
drug resistance in one single transfer. Plasmid 4 (size =
63,589 bp; IncL/M) was positive for the OXA-48-
encoding gene. Two additional plasmids with sizes of 72,
679 bp (plasmid 3; IncFII) and 6656 bp (plasmid 5;
Col440I) did not carry any resistance or virulence genes
(Additional file 1: Fig. S7D and S7F).
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When comparing these plasmid sequences to the other
genomes (Fig. 3, Additional file 1: Fig. S2, and Add-
itional file 1: Fig. S3B), we noticed that two non-K. pneu-
moniae ST307 isolates were also positive for plasmid 1
(NDM-1): (i) PBIO1963 is an E. coli ST362 isolate ob-
tained on September 10, 2019, from patient PT07, who
also carried K. pneumoniae ST307 (PBIO1955—obtained
on July 24, 2019). We suggest that K. pneumoniae
ST307 donated plasmid 1 to PBIO1963 within the pa-
tient. (ii) PBIO1961 is a K. pneumoniae ST395 isolate.
We did not obtain any additional carbapenem-resistant
isolates from this patient (PT12), which indicates inter-
patient transfer of resistance plasmids (Fig. 3); however,
our epidemiologic data do not support this suggestion as
no other ST307-positive patient was simultaneously
present on the same ward. Plasmids 2 and 4 were also
present in some non-ST307 genomes. K. pneumoniae
ST405 (PBIO1979) isolated on September 25, 2019, from
patient PT21 carried plasmid 2 (CTX-M-15). From the
same patient, we isolated K. pneumoniae ST307
(PBIO1936) on September 18, 2019, again suggesting
plasmid intra-bacterial species transfer within this pa-
tient. Plasmid 4 (OXA-48) was present in K. pneumoniae
ST147 (PBIO1999—isolated from patient PT16 on
October 2, 2019) and a K. pneumoniae ST307 isolate
(PBIO2000) obtained from the same patient on
September 4, 2019. Plasmid 4 was further carried by
PBIO1966, a C. freundii ST153 isolate obtained on
September 20, 2019, from patient PT02, who addition-
ally carried two K. pneumoniae ST307 isolates
(PBIO1958: August 5, 2019; PBIO1932: September 14,
2019). It was also present in E. cloacae ST45 (PBIO2014:
December 24, 2019), which was the only sequenced iso-
late from patient PT20. Again, these are examples for
putative inter-bacterial plasmid transfers within a patient
and among patients, respectively (Fig. 3). Inter-patient
transfer for PT20 is further supported by the epidemio-
logic data: PBIO2012 (ST307) was isolated on December
Fig. 2 Synteny plot of hybrid resistance/virulence plasmid 1 (pPBIO1953_NDM-1) and resistance plasmid 2 (pPBIO1953_CTX-M-15). The plot depicts
pairwise BlastN comparisons (E value 1e−10) between pPBIO1953 plasmid 1 and 2 and pK2044 and pKCTC2242. Alignment lengths were required to
be at least 1% of the smaller replicon in the comparison to be included. Direct comparisons are colored with red hues whereas reverse comparisons
are colored with blue hues. Boxes on top depict CDS on the forward strand, and those at the bottom depict CDS on the reverse strand. Boxes with a
dotted outline are annotated as pseudo CDS. Plasmid 1 of PBIO1953 combines virulence features, such as aerobactin, with acquired antimicrobial
resistance genes (e.g., blaNDM-1), which are missing from typical virulence plasmids of hypervirulent strains NTUH-K2044 and KCTC 2242. Note that
PBIO1953 plasmid 2 carries several metal resistance genes (pco and sil genes) present on hvKP virulence plasmids but absent from plasmid 1
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16, 2019, from a putative donor patient (PT10), who
stayed on the same ward as PT20.
Phenotypic experiments
We then investigated the hypothesis that K. pneumoniae
ST307 outbreak isolates combined high-level antibiotic
resistance with fitness, resilience, and virulence features.
In several phenotypic experiments, which were selected
based on their relevance in the clinical setting and on
the presence of resistance and virulence genes in ST307,
we investigated five K. pneumoniae ST307 isolates from
different time points during the outbreak and different
patients and hospitals (outbreak isolates), two K. pneu-
moniae ST395, and one K. pneumoniae ST405 (subse-
quently termed as the internal group). These were
compared to four external K. pneumoniae isolates with
Fig. 3 Putative plasmid transfer among K. pneumoniae isolates and between different bacterial genera. Solid arrows indicate putative intra-species transfer,
whereas dashed arrows indicate inter-bacterial transfer. The putative inter-patient transfer is illustrated through a question mark. Note that from PT12 (PBIO1961),
no additional carbapenem-resistant isolates were obtained and that no other ST307-positive patient was simultaneously present on the same ward whereas
inter-patient transfer for PT20 (PBIO2014) is further supported by the epidemiologic data. Line colors match the colors of transferred virulence/resistance
plasmids and are also shown next to the isolate names as circles. Closed circles—complete plasmid backbone (Megablast hits with identity ≥ 99%: coverage ≥
99%). Open circles—incomplete plasmid backbone (Megablast hits with identity ≥ 99%: coverage > 77% and < 99% (Additional file 2: Table S4)). a The
phylogenetic tree is based on distance-corrected MinHash dissimilarities between sequenced genomes and was inferred with FastME as part of JolyTree.
Shown at the branches is the rate of elementary quartets (REQ) for values ≥ 0.75 (circle diameter). b Timeline figure of plasmid transfer between July and
December 2019
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ST498, ST15, ST307, and ST86 including an archetypal,
hypervirulent K. pneumoniae strain (hvKP1), which are
unrelated to the outbreak. In addition, we included a
partially plasmid-cured variant (PCV1935) and controls
for each phenotypic experiment.
We observed no significant decreased growth rates
(p > 0.1 at 1, 2, 3, 4, and 5 h) of the ST307 isolates when
compared to the internal and external groups and to the
E. coli K-12 control (Fig. 4a), and also among each other.
PCV1935, which carried the incomplete NDM-1 plasmid
1, also showed comparable growth (μ1hST307, 1.05, vs.
μ1hPCV1935, 0.67; p = 0.9999). Interestingly, K. pneumo-
niae ST395 (PBIO1961) demonstrated a prolonged lag
phase (μ1hST307, 1.05, vs. μ1hPBIO1961, 0.51; p = 0.038),
which will be further explored in a prospective study.
Hypermucoviscosity experiments revealed that all K.
pneumoniae ST307 outbreak isolates showed strong
hypermucoviscosity (≥ 5 mm) (Fig. 5a), whereas in-
ternal K. pneumoniae ST395 and ST405 isolates did
not (p < 0.0001). Also, the external isolates showed a
negative hypermucoid phenotype, with the exception
of K. pneumoniae ST15 and, unsurprisingly, hvKP1.
Hypermucoviscosity of PCV1935 was not significantly
different from wildtype PBIO1935, which is interest-
ing given that both plasmid-encoded rmpA and
rmpA2 were lost during the curing process. On the
contrary, PBIO1961, which carried plasmid 1 (Figs. 3,
4, and 5, and Additional file 1: Figure S3B and S7B),
did not show hypermucoviscosity. This genome dem-
onstrated a different rmpA2-truncation and K locus
in comparison to the ST307 clone (Additional file 2:
Table S1). Also consider that the different phenotypes
might be due to synergy-dependent processes such
that plasmids have reduced impacts on other genetic
backgrounds than ST307. The hypermucoid pheno-
type appears to be a fine-tuned process. A recent
study [68] showed that loss of rmpC, which is a
newly identified gene that contributes to capsule
regulation in hvKp, resulted in decreased capsule gene
expression while simultaneously retaining hypermu-
coviscosity. Additional investigations will have to ad-
dress further which regulatory mechanisms contribute
to the hypermucoid phenotype in our outbreak clone.
Hypermucoviscosity is associated with invasive and
other aggressive types of infection, but recent litera-
ture suggests that this characteristic alone is not per
se responsible for a hypervirulent phenotype in Kleb-
siella spp. and that both terms should not be used
synonymously [5, 69].
Similar to the hypermucoviscosity experiments, we ob-
served significant differences between the K. pneumo-
niae ST307 outbreak isolates and the internal and
external groups regarding their siderophore secretion
capacities (p < 0.0001) (Fig. 5b, c). They all exhibited a
significant higher secretion with average bleaching zone
diameters of 20 mm, compared to 8.4 mm of internal
and 10.8 mm of external isolates (positive control, 12
mm). This is likely due to the presence of the NDM-1-
plasmid-encoded aerobactin, underlined by the results
shown for PCV1935, which demonstrated significantly
reduced siderophore secretion (p = 0.0025) (Fig. 5b, c).
Note that hvKP1 also showed increased siderophore se-
cretion compared to the internal group (p = 0.0126) but
in tendency less than the ST307 outbreak isolates, al-
though this difference was not significant (p = 0.35).
PBIO1961 registered within the result range of internal
and external isolates. This is likely due to a missense
mutation of plasmid-encoded iutA and/or the different
character of yersiniabactin (“unknown” ybt—Add-
itional file 2: Table S1). Given that hypermucoviscosity,
aerobactin secretion, and the metabolite transporter
PEG344 [70] are suggested key virulence features of hy-
pervirulent Klebsiella strains during infection, the above-
average performance, in addition to extensive antibiotic
resistance expression, provides one step closer to
explaining why this outbreak evolved. PBIO2009 (exter-
nal ST307 isolate), which does not possess typical hvKp-
associated features like peg-344, iucA, and rmpA [11],
showed negative hypermucoid and iron uptake pheno-
types (Fig. 5a–c), possibly strengthening our assumption.
We were then interested in whether the K. pneumo-
niae ST307 outbreak isolates also showed sufficient cap-
acity for survival and resilience in the clinical setting and
host. Serum survival experiments revealed high survival
rates for all isolates, and together with similar strong
biofilm formation capacities (Fig. 4b, c), this suggests
that the outbreak K. pneumoniae ST307 isolates had
good abilities to resist clinical challenges. Comparable
results were also obtained for desiccation resilience
(Fig. 4d). Despite that internal and external groups
showed a tendency to survive 6 days of desiccation at
higher rates than K. pneumoniae ST307, the differ-
ence was not significant after applying Bonferroni
correction (outbreak vs. internal group: p = 0.5488;
outbreak vs. external group: p = 0.0730; internal vs.
external group: p > 0.9999).
The genetic characterization revealed several heavy
metal efflux genes on plasmid 2. Heavy metal com-
pounds, such as zinc oxide or copper sulfate, are regu-
larly used as feed supplements in livestock, e.g., for
prevention of gastro-intestinal disorders and growth
promotion in piglets [71], and co-selection of heavy
metal and antimicrobial resistance has been increas-
ingly reported [72, 73]. We thus investigated the bac-
teria’s tolerance by determining minimum inhibitory
concentrations (MICs) to copper, zinc, and silver
(Additional file 2: Table S1). A MIC value of 1024 μg/
mL for copper sulfate was obtained for almost all K.
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pneumoniae isolates, both outbreak, internal, and ex-
ternal group isolates (control ATCC25922, 256 μg/
mL), which is an average copper tolerance for Entero-
bacteriaceae [74]. Interestingly, hvKP1 showed a re-
duced MIC for copper sulfate (256 μg/mL). We
observed similar results for zinc and silver for all iso-
lates (MIC zinc chloride 512 μg/mL, control 256 μg/
mL; silver nitrate 4 μg/mL, control 4 μg/mL), again
with the exception of hvKP1 demonstrating a reduced
MIC for zinc (256 μg/mL).
Discussion
To the best of our knowledge, this is the first outbreak
in Germany of a K. pneumoniae ST307 clone that pro-
duced both NDM-1 and OXA-48 carbapenemases and
showed resistance against colistin. It was first detected at
Fig. 4 Results of phenotypic experiments without significant differences. Red symbols: K. pneumoniae ST307 outbreak isolates; yellow symbols: K.
pneumoniae non-ST307 internal isolates; blue symbols: K. pneumoniae external isolates. Red circle: occurrence of plasmid 1 in K. pneumoniae ST307
outbreak isolates and PBIO1961; orange circle: occurrence of plasmid 2 in K. pneumoniae ST307 outbreak isolates, PBIO1979, and PCV1935; red
open circle: incomplete plasmid 1 in PCV1935. Isolates belonging to ST307 are highlighted in dark gray, and all other isolates in light gray. a
Results of growth experiments in LB medium are given as mean values of CFU/mL for each isolate over 5 h. Abbreviations: n.s., not significant. b
Results of serum survival experiments are given as mean values and standard deviation of CFU/mL for each isolate before (inoculum: circles) and
after 4 h of incubation in human serum (squares). c Results of biofilm formation experiments are given as absorbance values (mean with
coefficient of variation) of crystal violet at 590 nm for each isolate after 3 h of incubation. d Results of desiccation tolerance experiments are given
as mean values and standard deviation of colony-forming units (CFU) per milliliter (CFU/mL) for each isolate before (inoculum: circles) and after
6 days of desiccation (squares)
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Fig. 5 Results of phenotypic experiments with significant differences. Red symbols: K. pneumoniae ST307 outbreak isolates; yellow symbols: K. pneumoniae non-
ST307 internal isolates; blue symbols: K. pneumoniae external isolates. Red circle: occurrence of plasmid 1 in K. pneumoniae ST307 outbreak isolates and PBIO1961;
orange circle: occurrence of plasmid 2 in K. pneumoniae ST307 outbreak isolates, PBIO1979, and PCV1935; red open circle: incomplete plasmid 1 in PCV1935.
Isolates belonging to ST307 are highlighted in dark gray, and all other isolates in light gray. a Results of the hypermucoviscosity test are given as mean values
and standard deviation of the string length in millimeters (mm) for each isolate. b Results of siderophore secretion tests are given as mean values and standard
deviation of the secretion zone diameter in millimeters (mm) for each isolate. c Siderophore secretion experiment on CAS-Agar of six exemplary isolates:
PBIO1953 (outbreak isolate [ST307]), PBIO1951 (internal control [ST395]), PBIO2008 (external control [ST15]), PBIO2009 (external control [ST307]), hvKP1 (external
hypervirulent control [ST86]), and PCV1935 (outbreak plasmid-cured variant [ST307]). Yellow areas around colonies indicate siderophore secretion. Abbreviations
and symbols: n.s., not significant; ****p value < 0.0001; ***p value < 0.001; **p value < 0.01
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the University Medicine Greifswald in June 2019 from a
tracheal secretion sample [19]. As we did not detect any
mcr-genes, we suggest that colistin resistance is due to
chromosomal point mutations including the two-
component systems PhoP/PhoQ and PmrA/PmrB, which
have been previously described in this context [67].
When placing our outbreak clone in a global frame,
a cluster of KPC-producing ST307 genomes from the
UK was the phylogenetically closest. Interestingly, this
cluster was part of a study from 2017 revealing that
these genomes harbor genetic features important for
clinical and host adaptation, in particular glycogen
synthesis [3]. Our outbreak isolates have seemingly
developed different resistance phenotypes and viru-
lence strategies, and the UK cluster is thus probably
not the true, most likely recent common ancestor of
the ST307 outbreak clone.
Although we did not unequivocally verify the hypervir-
ulent character of this clone, it demonstrated hypermu-
coviscosity, iron uptake, and metabolite transporter
capacities—which are relevant for invasive infection and
assertiveness in different host environments [41, 69,
70]—comparable to an archetypal hvKp strain [54]. The
fact that these key hypervirulence features in addition to
disinfectant resistance are found on mutual virulence/re-
sistance plasmids in extensively drug-resistant isolates is
concerning and has tremendous public health implica-
tions as these mobile genetic elements may be trans-
ferred across different bacteria [75]. Our previous work,
and those of others, suggests that the combination of
high-level drug resistance and virulence is a good com-
bination for the successful spread of bacterial pathogens
[3, 53, 76–79]. On the other hand, the co-carriage of
plasmid-encoded heavy metal efflux genes did not sig-
nificantly impact the phenotypic tolerance in the study’s
K. pneumoniae outbreak isolates, pointing towards that
this capacity is less likely a major contributor to the
clone’s success in this outbreak situation.
We detected identical plasmids among ST307 and other
K. pneumoniae isolates as well as other bacterial genera,
exacerbating the threat this clone poses across clinical set-
tings. Note, however, that it is possible that ST307 has a
greater tolerance towards possible fitness costs of the car-
ried plasmids, implying that donated plasmids might have
reduced impacts in other genetic backgrounds [56]. We
suggest that the K. pneumoniae ST307 isolates are the
general plasmid donors; they were all isolated at an earlier
date than the putative acceptor isolates and more inde-
pendent variants accumulated in some putative acceptor
plasmids compared to the K. pneumoniae ST307 donor
plasmids (Additional file 2: Table S3). The fact that ST395
occurred three times among all isolates but only ST395
PBIO1961 was positive for plasmid 1 additionally
strengthens this assumption.
Interestingly, although most hvKp show susceptibility
to antimicrobials [44], hvKp with AMR have increasingly
emerged in the last decade [80–83], which might be an
ongoing trend.
Conclusions
While the emergence of XDR, virulent, and fit pathogens
is worrisome, our study helps to implement control
measures and calls for prospective surveillance strategies
that take the emergence of “converging” cKp and hvKp
pathotypes into account.
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